CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 438 enrolled
Drug / intervention
SofLens in investigational solution +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01391364
NCT01391364N/ACompleted
CompareCT.gov

A Study to Evaluate the Product Performance of a Modified Contact Lens

Bausch & Lomb Incorporated·interventional·Posted Jul 12, 2011·Updated Sep 30, 2020

In Brief

A clinical study evaluating SofLens in investigational solution and SofLens in currently marketed solution for Myopia. Completed, enrolled 438 participants across 1 site.

Detailed Summary

This study is being conducted to evaluate the product performance of SofLens daily disposable contact lenses packaged in an investigational Test solution versus SofLens daily disposable contact lenses packaged in the currently marketed solution (Control), as it relates to comfort when worn by adapted soft contact lens wearers on a daily-wear basis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 12, 2011
Enrollment StartApr 1, 2011
Primary CompletionJun 1, 2011
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.0 years ago

Interventions

SofLens in investigational solutiondevice

SofLens in investigational solution, worn on a daily disposable basis for 7 days.

SofLens in currently marketed solutiondevice

SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.